ACOG 委员会意见第 743 号摘要:妊娠期低剂量阿司匹林的使用
美国妇产科医师学会(ACOG)发布委员会意见,支持美国预防服务工作组(USPSTF)关于妊娠期低剂量阿司匹林预防子痫前期的指南标准。推荐子痫前期高风险女性自妊娠 12 周至 28 周(最好在 16 周前)开始每日服用低剂量阿司匹林(81 mg/d)并持续至分娩;存在多个中度风险因素者应考虑预防性使用。无高风险因素时,现有证据不支持用于预防早期流产、胎儿生长受限、死胎或早产。
要点
- 子痫前期高风险女性推荐每日低剂量阿司匹林(81 mg)预防,于妊娠 12 周至 28 周开始(最好 16 周前)并持续至分娩。
- 存在一个以上中度风险因素者应考虑低剂量阿司匹林预防。
- 无高风险因素时,现有证据不支持用低剂量阿司匹林预防早期流产、胎儿生长受限、死胎或早产。
核心结论
- ACOG 与母胎医学会(SMFM)支持 USPSTF 关于预防子痫前期的低剂量阿司匹林指南标准。
- 妊娠期每日低剂量阿司匹林被认为安全,且与较低的严重母体或胎儿并发症可能性相关。
研究设计与样本
- ACOG 发布的委员会意见,基于妊娠期高血压工作组报告及 USPSTF 指南。
主要发现
- ACOG 工作组报告推荐对有早发型子痫前期并小于 34 0/7 周早产史的女性,或既往多次妊娠并发子痫前期的女性,自妊娠早期末开始每日低剂量阿司匹林。
- USPSTF 发布了类似指南,但低剂量阿司匹林使用的适应证列表更广泛。
关键数值与推荐
- 推荐子痫前期高风险女性进行低剂量阿司匹林(81 mg/d)预防,应于妊娠 12 周至 28 周之间开始(最好在 16 周前),并每日持续至分娩。
- 对于存在多个中度子痫前期风险因素中一个以上的女性,应考虑低剂量阿司匹林预防。
- 子痫前期风险定义为存在一个或多个高风险因素(子痫前期病史、多胎妊娠、肾脏疾病、自身免疫性疾病、1 型或 2 型糖尿病、慢性高血压)或一个以上多个中度风险因素(初次妊娠、孕妇年龄 35 岁或以上、体重指数大于 30、子痫前期家族史、社会人口学特征、个人病史因素)。
- 无子痫前期高风险因素时,当前证据不支持使用预防性低剂量阿司匹林来预防早期妊娠丢失、胎儿生长受限、死胎或早产。
临床怎么用
- 对子痫前期高风险女性,推荐每日低剂量阿司匹林(81 mg)预防,于妊娠 12 周至 28 周开始(最好在 16 周前),持续至分娩。
- 对存在一个以上中度风险因素的女性,应考虑低剂量阿司匹林预防。
- 无高风险因素时,当前证据不支持用低剂量阿司匹林预防早期妊娠丢失、胎儿生长受限、死胎或早产。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Low-dose aspirin has been used during pregnancy, most commonly to prevent or delay the onset of preeclampsia. The American College of Obstetricians and Gynecologists issued the Hypertension in Pregnancy Task Force Report recommending daily low-dose aspirin beginning in the late first trimester for women with a history of early-onset preeclampsia and preterm delivery at less than 34 0/7 weeks of gestation, or for women with more than one prior pregnancy complicated by preeclampsia. The U.S. Preventive Services Task Force published a similar guideline, although the list of indications for low-dose aspirin use was more expansive. Daily low-dose aspirin use in pregnancy is considered safe and is associated with a low likelihood of serious maternal, or fetal complications, or both, related to use. The American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine support the U.S. Preventive Services Task Force guideline criteria for prevention of preeclampsia. Low-dose aspirin (81 mg/day) prophylaxis is recommended in women at high risk of preeclampsia and should be initiated between 12 weeks and 28 weeks of gestation (optimally before 16 weeks) and continued daily until delivery. Low-dose aspirin prophylaxis should be considered for women with more than one of several moderate risk factors for preeclampsia. Women at risk of preeclampsia are defined based on the presence of one or more high-risk factors (history of preeclampsia, multifetal gestation, renal disease, autoimmune disease, type 1 or type 2 diabetes, and chronic hypertension) or more than one of several moderate-risk factors (first pregnancy, maternal age of 35 years or older, a body mass index greater than 30, family history of preeclampsia, sociodemographic characteristics, and personal history factors). In the absence of high risk factors for preeclampsia, current evidence does not support the use of prophylactic low-dose aspirin for the prevention of early pregnancy loss, fetal growth restriction, stillbirth, or preterm birth.
引用
- ACOG Committee Opinion No. 743 Summary: Low-Dose Aspirin Use During Pregnancy. Obstet Gynecol. 2018. PMID: 29939936. doi:10.1097/AOG.0000000000002709
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。